YUMANITY THERAPEUTICS INC (YMTX) Stock Balance Sheet
NASDAQ:YMTX - Nasdaq - US98872L1026 - Common Stock - Currency: USD
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.42M | 35.10M | 80.80M | 25.00M | 28.80M | |||
| Marketable Securities | 0.00 | 1.40M | 4.50M | 44.50M | 89.60M | |||
| Receivables | 0.00 | 5.00M | N/A | N/A | N/A | |||
| Other Current Assets | 664.00K | 1.21M | 2.30M | 1.40M | 2.50M | |||
| Total Current Assets | 9.08M | 42.71M | 87.60M | 70.90M | 120.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 449.00K | 18.93M | 24.60M | 13.00M | 14.50M | |||
| Investments And Advances | 0.00 | 366.00K | 400.00K | N/A | N/A | |||
| Other Non-Current Assets | 50.00K | 928.00K | 2.30M | 800.00K | 800.00K | |||
| Total Non-Current Assets | 499.00K | 20.22M | 27.20M | 13.80M | 15.20M | |||
| TOTAL ASSETS | 9.58M | 62.93M | 114.80M | 84.70M | 136.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 5.85M | 3.10M | N/A | N/A | |||
| Accrued Expenses | 1.44M | 9.91M | 12.30M | 8.00M | 6.70M | |||
| Accounts Payable | 1.69M | 1.84M | 7.40M | 2.30M | 1.90M | |||
| Other Current Liabilities | 979.00K | 5.06M | 8.10M | N/A | 0.00 | |||
| Total Current Liabilities | 4.10M | 22.66M | 30.90M | 10.30M | 8.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 7.36M | 13.30M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 9.41M | 14.50M | 12.00M | 13.20M | |||
| Total Non-Current Liabilities | 0.00 | 16.77M | 27.70M | 12.00M | 13.20M | |||
| TOTAL LIABILITIES | 4.10M | 39.44M | 58.60M | 22.30M | 21.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -208.90M | -187.31M | -147.80M | -336.70M | -277.50M | |||
| Additional Paid In Capital | 214.37M | 210.80M | 204.00M | 399.00M | 391.80M | |||
| Common Shares | 11.00K | 11.00K | 0.00 | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 10.86M | 10.64M | 10.20M | 2.60M | 2.50M | |||
| Tangible Book Value per Share | 0.50 | 2.21 | 5.51 | 24.00 | 45.72 | |||
| Total Shareholders' Equity | 5.48M | 23.50M | 56.20M | 62.40M | 114.30M | |||
| TOTAL LIABILITIES AND EQUITY | 9.58M | 62.93M | 114.80M | 84.70M | 136.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.31 | 0.24 | N/A | N/A | |||
| Current Ratio | 2.21 | 1.88 | 2.83 | 6.88 | 14.06 | |||
| Return On Assets (ROA) | -334.06% | -62.77% | -50.08% | -69.81% | -45.43% | |||
| Return On Equity (ROE) | -584.37% | -168.12% | -102.30% | -94.76% | -54.09% | |||
All data in USD , ROIC based on taxRate of 0.21